首页> 外文期刊>European urology >Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: Results of a prospective randomised trial
【24h】

Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: Results of a prospective randomised trial

机译:术中连续去甲肾上腺素输注与限制性延迟水合作用显着降低了接受开放性根治性膀胱切除术的患者的输血需求:一项前瞻性随机试验结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background Open radical cystectomy (ORC) is associated with substantial blood loss and a high incidence of perioperative blood transfusions. Strategies to reduce blood loss and blood transfusion are warranted. Objective To determine whether continuous norepinephrine administration combined with intraoperative restrictive hydration with Ringer's maleate solution can reduce blood loss and the need for blood transfusion. Design, setting, and participants This was a double-blind, randomised, parallel-group, single-centre trial including 166 consecutive patients undergoing ORC with urinary diversion (UD). Exclusion criteria were severe hepatic or renal dysfunction, congestive heart failure, and contraindications to epidural analgesia. Intervention Patients were randomly allocated to continuous norepinephrine administration starting with 2 μg/kg per hour combined with 1 ml/kg per hour until the bladder was removed, then to 3 ml/kg per hour of Ringer's maleate solution (norepinephrine/low-volume group) or 6 ml/kg per hour of Ringer's maleate solution throughout surgery (control group). Outcome measurements and statistical analysis Intraoperative blood loss and the percentage of patients requiring blood transfusions perioperatively were assessed. Data were analysed using nonparametric statistical models. Results and limitations Total median blood loss was 800 ml (range: 300-1700) in the norepinephrine/low-volume group versus 1200 ml (range: 400-2800) in the control group (p < 0.0001). In the norepinephrine/low-volume group, 27 of 83 patients (33%) required an average of 1.8 U (±0.8) of packed red blood cells (PRBCs). In the control group, 50 of 83 patients (60%) required an average of 2.9 U (±2.1) of PRBCs during hospitalisation (relative risk: 0.54; 95% confidence interval [CI], 0.38-0.77; p = 0.0006). The absolute reduction in transfusion rate throughout hospitalisation was 28% (95% CI, 12-45). In this study, surgery was performed by three high-volume surgeons using a standardised technique, so whether these significant results are reproducible in other centres needs to be shown. Conclusions Continuous norepinephrine administration combined with restrictive hydration significantly reduces intraoperative blood loss, the rate of blood transfusions, and the number of PRBC units required per patient undergoing ORC with UD.
机译:背景根治性膀胱切除术(ORC)与大量失血和围手术期输血的高发生率相关。必须采取减少出血和输血的策略。目的确定连续去甲去甲肾上腺素联合术中马来酸林格液限制性水合作用是否可以减少失血量和输血量。设计,设置和参与者这是一项双盲,随机,平行分组,单中心试验,包括166名接受ORC并伴有尿流改道(UD)的连续患者。排除标准是严重的肝或肾功能不全,充血性心力衰竭以及硬膜外镇痛的禁忌症。干预患者被随机分配为连续连续去甲肾上腺素,开始于每小时2μg/ kg联合每小时1 ml / kg,直到取出膀胱,然后每小时3 mg / kg的林格氏马来酸盐溶液(去甲肾上腺素/小剂量组) )或整个手术中每小时6毫升/千克的林格氏马来酸盐溶液(对照组)。结果测量和统计分析评估术中失血和围手术期需要输血的患者百分比。使用非参数统计模型分析数据。结果与局限性去甲肾上腺素/小剂量组的总中位数失血量为800 ml(范围:300-1700),而对照组为1200 ml(范围:400-2800)(p <0.0001)。在去甲肾上腺素/小剂量组中,83名患者中有27名(33%)平均需要1.8 U(±0.8)堆积红细胞(PRBC)。在对照组中,住院期间83例患者中有50例(60%)平均需要2.9 U(±2.1)PRBC(相对风险:0.54; 95%置信区间[CI],0.38-0.77; p = 0.0006)。整个住院期间的输血率绝对降低了28%(95%CI,12-45)。在这项研究中,手术是由三名大手术量的外科医生采用标准化技术进行的,因此,需要证明这些重要结果在其他中心是否可重现。结论连续去甲肾上腺素联合限制性水合作用可显着降低术中失血量,输血率和每位接受ORC UD的患者所需的PRBC单位数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号